Incyte Corp Sustainability Reports
Incyte Corporation is a global biopharmaceutical company focusing on the discovery, development, and commercialization of proprietary therapeutics. Its research predominantly targets oncology, hematology, dermatology, and inflammation and autoimmunity areas.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300Z4WN6JVZ3T4680
FIGI: BBG001S8Q6N2
18 reports from 2007 to 2025
